CHRISTIANSON MARK (Business Development Director) sold 0.4% of their position (917.00 shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $733.60 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/16/2026ACC: 0001709738-26-000008
Officer· Business Development Director
Since Feb 2026
-917.00
Net shares
Net seller
$733.60
Total sold
2
Open market trades
0B · 2S
2
Total transactions
917.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−817.00
Price / share
$0.80
Trade value
$653.60
% of position
0.4%
3/12/2026
215.20K→214.38K
Common Stock
Direct
Shares
−100.00
Price / share
$0.80
Trade value
$80.00
% of position
0.0%
3/13/2026
214.38K→214.28K
Total
Net shares
−917.00
Net value
-$733.60
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | S · Sale | −817.00 | $0.80 | $653.60 | 0.4% | 215.20K | 214.38K |
| Common Stock Direct | 3/13/2026 | S · Sale | −100.00 | $0.80 | $80.00 | 0.0% | 214.38K | 214.28K |
| Total | −917.00 | -$733.60 | ||||||
Derivative Transactions0
No derivative transactions reported